Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Huntington Disease

fluorodeoxyglucose f18 has been researched along with Huntington Disease in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (20.97)	18.7374
1990's	11 (17.74)	18.2507
2000's	10 (16.13)	29.6817
2010's	23 (37.10)	24.3611
2020's	5 (8.06)	2.80

Authors

Authors	Studies
Delva, A; Koole, M; Michiels, L; Van Laere, K; Vandenberghe, W	1
Axer, H; Drescher, R; Gühne, F; Schroeter, T; Schwab, M	1
Camacho, V; Horta-Barba, A; Kulisevsky, J; Martinez-Horta, S; Pagonabarraga, J; Pérez-Pérez, J; Sampedro, F	1
Delva, A; Van Laere, K; Vandenberghe, W	1
Anderberg, L; Budtz-Jørgensen, E; Hellem, MNN; Hjermind, LE; Larsen, VA; Law, I; Nielsen, JE; Vinther-Jensen, T	1
Kim, CK; Singhal, T	1
Camacho, V; Carceller-Sindreu, M; Carrió, I; Fernández-León, A; Gomez-Anson, B; Horta-Barba, A; Kulisevsky, J; Lopez-Mora, DA; Lozano-Martinez, GA; Martínez-Horta, S; Pagonabarraga, J; Perez-Perez, J; Sampedro, F	1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Gandolfo, F; Nestor, P; Nobili, F; Orini, S; Pagani, M; Walker, Z	1
Belichenko, NP; Chin, FT; Condon, C; James, ML; Kuan, J; Longo, FM; Miao, Z; Semaan, S; Shuhendler, AJ; Simmons, DA	1
Camacho, V; Carrió, I; Domènech, A; Duch, J; Estorch, M; Fernández, A; Flotats, A; Fuentes, F; Kulisevsky, J; López Mora, DA; Marín-Lahoz, J; Martínez-Horta, S; Pérez-Perez, J; Sampedro, F	1
Buchholz, HG; Heinrich, I; Hoffmann, MA; Michels, S; Rosar, F; Schreckenberger, M; Schweiger, S; Tüscher, O	1
Bastianello, M; Biafore, F; Depetris, TS; Peralta, C	1
Hoberück, S; Kotzerke, J; Martino, F; Michler, E; Platzek, I	1
Berti, V; Biggeri, A; Bucciantini, S; Catelan, D; Di Lorenzo, N; Gallina, P; Ghelli, E; Lombardini, L; Mascalchi, M; Massacesi, L; Mechi, C; Paganini, M; Porfirio, B; Pradella, S; Romoli, AM; Saccardi, R; Vannelli, GB	1
Herben-Dekker, M; Jurgens, CK; Kremer, HP; Leenders, KL; Roos, RA; Spikman, JM; van Oostrom, JC; Witjes-Ané, MN	1
Dobričić, V; Kostić, VS; Ralić, V; Stanković, I; Stefanova, E	1
He, Z; Mo, C; Mu, S; Peng, W; Qu, J; Wang, J; Zhang, J; Zhao, Z; Zhou, G	1
Bohlen, S; Deppe, M; Gigengack, F; Hermann, S; Hölzner, E; Jacobs, AH; Kugel, H; Lippross, V; Lücke, M; Nguyen, HP; Osada, N; Reilmann, R; Riess, O; Schäfers, K; Schäfers, M; Von Hörsten, S	1
Ciarmiello, A	1
Cannella, M; Ciarmiello, A; Frati, L; Giovacchini, G; Mansi, L; Martino, T; Orobello, S; Romanelli, P; Squitieri, F	1
Bech, S; Ehlers, L; Eiberg, H; Gjedde, A; Hasholt, L; Hjermind, LE; Lundorf, E; Nielsen, JE; Nørremølle, A; Petersen, T	1
Bartolozzi, B; Bertini, E; Bucciantini, S; Crescioli, C; De Cristofaro, MT; Di Lorenzo, N; Gadda, D; Gallina, P; Lombardini, L; Marini, M; Mascalchi, M; Mechi, C; Paganini, M; Piacentini, S; Pinzani, P; Porfirio, B; Pupi, A; Romoli, AM; Saccardi, R; Salvianti, F; Sarchielli, E; Urbani, S; Vannelli, GB	1
Haas, RH; Le, T; Markham, J; Perlmutter, JS; Powers, WJ; Videen, TO	1
Gupta, S; Misra, G; Pant, MC; Seth, PK	1
Ciarmiello, A; Esmaeilzadeh, M; Jankovic, J; Squitieri, F	1
Allain, P; Bachoud-Levi, AC; Bonneau, D; Chauviré, V; Dubas, F; Fasotti, L; Gaura, V; Le Gall, D; Prundean, A; Remy, P; Sherer-Gagou, C; Verny, C	1
Blockx, I; Boisgard, R; Dollé, F; Dubois, A; Jego, B; Jonckers, E; Kuhnast, B; Nguyen, HP; Raber, K; Siquier, K; Tavitian, B; Van Camp, N; Van der Linden, A; Verhoye, M; Von Hörsten, S	1
Bruselli, L; Ciarmiello, A; Elifani, F; Giovacchini, G; Orobello, S; Squitieri, F	1
An, YS; Cho, JW; Choi, JY; Kim, BT; Kim, YK; Lee, KH; Lee, SJ; Lee, WY	1
Eidelberg, D	1
Bak, TH; Barker, RA; Ho, AK; Manly, T; Nestor, PJ; Robbins, TW; Rosser, AE; Sahakian, BJ	1
Brownell, AL; Cicchetti, F; Jokivarsi, K; Saint-Pierre, M; Sarkar, A; Wang, X; Yu, M; Zhu, A	1
Leenders, KL; Maguire, RP; Pruim, J; Roos, RA; van Oostrom, JC; Veenma-van der Duin, L; Verschuuren-Bemelmans, CC	1
Cannella, M; Ciarmiello, A; Frati, L; Lastoria, S; Rubinsztein, DC; Simonelli, M; Squitieri, F	1
Dhawan, V; Eidelberg, D; Feigin, A; Guttman, M; Ma, Y; Mattis, P; Paulsen, JS; Tang, C; Zgaljardic, D	1
Kuhl, DE; Markham, CH; Metter, EJ; Phelps, ME; Riege, WH; Winter, J	1
Mazziotta, JC; Phelps, ME; Schelbert, HR	1
Kuhl, DE; Markham, CH; Metter, EJ; Riege, WH	1
Hoskinson, M; Kremer, B; Maguire, C; Martin, WR; McEwan, A	1
Azari, NP; Pietrini, P	1
Aulich, A; Boecker, H; Feinendegen, LE; Herzog, H; Kuwert, T; Lange, HW; Nayak, U; Titz, H; Wang, BC	1
Aulich, A; Feinendegen, LE; Herzog, H; Kuwert, T; Lange, HW; Noth, J; Scholz, D; Schwarz, M; Töpper, R	1
Antonini, A; Boesiger, P; de Yébenez, JG; Leenders, KL; Maguire, RP; Meier, D; Sanchez-Pernaute, R; Spiegel, R; Vontobel, P; Weigell-Weber, M; Weindl, A	1
Otsuka, M; Taniwaki, T	1
Büll, U; Meyer, PT; Sabri, O; Schreckenberger, M; Setani, K; Zeggel, T	1
Araujo, DM; Cherry, SR; Kornblum, HI; Tatsukawa, KJ; Toyokuni, T	1
Antonini, A; Eidelberg, D; Feigin, A; Kuenig, G; Leenders, KL; Missimer, J; Moeller, JR; Spetsieris, P	1
Brownell, AL; Brownell, GL; Davenport, PD; Elmaleh, DR; Hantraye, P; Isacson, O; Madras, BK; Maziere, M; Riche, D; Schumacher, JM	1
Brandt, J; Dannals, RF; Folstein, SE; Mayberg, HS; Peyser, CE; Starkstein, SE	1
Ammann, W; Clark, CM; Grochowski, EW	1
Ammann, W; Clark, C; Hayden, MR; Martin, WR; Shtybel, W; Stoessl, AJ	1
Ammann, W; Clark, CM; Hayden, MR; Martin, WR; Ty, P	1
Heiss, WD; Herholz, K; Pawlik, G; Szelies, B; Wienhard, K	1
Mazziotta, JC; Phelps, ME	1
Alavi, A; Alavi, J; Chawluk, J; Dann, R; Kushner, M; Reivich, M	1
Adam, MJ; Ammann, W; Clark, C; Harrop, R; Hayden, MR; Hollenberg, S; Martin, WR; Rogers, J; Ruth, T; Stoessl, AJ	1
Baxter, LR; Hoffman, JM; Huang, SC; Kuhl, DE; Lanto, AB; Mazziotta, JC; Pahl, JJ; Phelps, ME; Riege, WH; Wapenski, JA	1
Berent, S; Betley, A; Hichwa, R; Markel, D; Penney, JB; Rothley, J; Starosta-Rubinstein, S; Young, AB	1
Bol, A; Cogneau, M; De Volder, A; Evrard, P; Goffinet, AM; Lyon, G; Michel, C	1
Berent, S; Buchtel, HA; Giordani, B; Hichwa, R; Lehtinen, S; Markel, D; Penney, JB; Starosta-Rubinstein, S; Young, AB	1
Hayden, MR; Hildebrand, AM; Martin, WR; Pate, BD; Stoessl, AJ; Suchowersky, O	1
Kuhl, DE; Markham, CH; Mazziotta, JC; Metter, EJ; Phelps, ME; Riege, WH	1

Reviews

7 review(s) available for fluorodeoxyglucose f18 and Huntington Disease

Article	Year
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Amyotrophic Lateral Sclerosis; Brain; Fluorodeoxyglucose F18; Humans; Huntington Disease; Positron-Emission Tomography; Radiopharmaceuticals	2018
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders. Current neurology and neuroscience reports, 2019, 06-29, Volume: 19, Issue:8 Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon	2019
Brain networks and clinical penetrance: lessons from hyperkinetic movement disorders. Current opinion in neurology, 2003, Volume: 16, Issue:4 Topics: Brain; Carrier Proteins; Dystonia Musculorum Deformans; Fluorodeoxyglucose F18; Humans; Huntington Disease; Hyperkinesis; Molecular Chaperones; Nerve Net; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron computed tomography for studies of myocardial and cerebral function. Annals of internal medicine, 1983, Volume: 98, Issue:3 Topics: Alzheimer Disease; Animals; Brain; Brain Neoplasms; Cardiomyopathies; Cerebrovascular Disorders; Deoxyglucose; Dogs; Epilepsy; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Huntington Disease; Regional Blood Flow; Tomography, Emission-Computed	1983
[Functional imaging for disorders of basal ganglia]. Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:1 Topics: Basal Ganglia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	1999
Positron emission tomography: human brain function and biochemistry. Science (New York, N.Y.), 1985, May-17, Volume: 228, Issue:4701 Topics: Acoustic Stimulation; Bipolar Disorder; Brain; Brain Diseases; Brain Neoplasms; Cerebrovascular Circulation; Cerebrovascular Disorders; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Kinetics; Mental Disorders; Neurotransmitter Agents; Oxygen Consumption; Pharmaceutical Preparations; Pharmacology; Photic Stimulation; Tomography, Emission-Computed; Visual Cortex	1985
Positron emission tomography imaging of regional cerebral glucose metabolism. Seminars in nuclear medicine, 1986, Volume: 16, Issue:1 Topics: Aging; Brain; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Dementia; Deoxyglucose; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Parkinson Disease; Radiography; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed	1986

Trials

6 trial(s) available for fluorodeoxyglucose f18 and Huntington Disease

Article	Year
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:9 Topics: Adult; Brain Tissue Transplantation; Cerebral Cortex; Corpus Striatum; Female; Fetal Tissue Transplantation; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Neuroimaging; Humans; Huntington Disease; Iodobenzenes; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Receptors, Dopamine D2; Treatment Outcome	2014
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:7 Topics: Adult; Aged; Biomarkers; Brain; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Growth Factors; Placebos; Positron-Emission Tomography; Riluzole	2009
Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Experimental neurology, 2010, Volume: 222, Issue:1 Topics: Adult; Brain Tissue Transplantation; Cell Movement; Corpus Striatum; Enzyme-Linked Immunosorbent Assay; Female; Fetus; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation; HLA Antigens; Humans; Huntington Disease; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Tissue Proteins; Neurologic Examination; Protein Binding; Receptors, Dopamine D2; RNA, Messenger; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon	2010
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:2 Topics: Adult; Atrophy; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Huntington Disease; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity	2006
Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1995, Volume: 5, Issue:4 Topics: Anticonvulsants; Case-Control Studies; Caudate Nucleus; Deoxyglucose; Double-Blind Method; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Lamotrigine; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Thalamus; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Triazines	1995
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:11 Topics: Adult; Brain; Brain Chemistry; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Heterozygote; Humans; Huntington Disease; Male; Radiopharmaceuticals; Tomography, Emission-Computed	2001

Other Studies

49 other study(ies) available for fluorodeoxyglucose f18 and Huntington Disease

Article	Year
Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study. Neurology, 2022, 01-04, Volume: 98, Issue:1 Topics: Adult; Brain; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Middle Aged; Positron-Emission Tomography; Synaptic Vesicles	2022
Differentiation of Reversible Hemichorea Due to Vitamin B12 Deficiency From Huntington Disease Via FDG PET. Clinical nuclear medicine, 2022, Sep-01, Volume: 47, Issue:9 Topics: Chorea; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Positron Emission Tomography Computed Tomography; Vitamin B 12 Deficiency	2022
Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease. Journal of neuroscience research, 2023, Volume: 101, Issue:6 Topics: Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Problem Solving	2023
Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease. Movement disorders : official journal of the Movement Disorder Society, 2023, Volume: 38, Issue:8 Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Membrane Glycoproteins; Movement Disorders; Nerve Tissue Proteins; Positron-Emission Tomography	2023
Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction. PloS one, 2021, Volume: 16, Issue:6 Topics: Adult; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Trinucleotide Repeat Expansion	2021
Putaminal Hypometabolism Exceeding Caudate Abnormalities on 18F-FDG PET in Huntington Disease. Clinical nuclear medicine, 2017, Volume: 42, Issue:7 Topics: Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Middle Aged; Positron-Emission Tomography; Putamen	2017
Structural and metabolic brain correlates of apathy in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:7 Topics: Aged; Apathy; Atrophy; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Huntington Disease; Imaging, Three-Dimensional; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed	2018
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31. Human molecular genetics, 2018, 08-15, Volume: 27, Issue:16 Topics: Animals; Cerebral Cortex; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Huntington Disease; Isoleucine; Male; Mice; Microglia; Morpholines; Positron-Emission Tomography; Protein Binding; Receptors, GABA; Receptors, Nerve Growth Factor	2018
Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters. Clinical nuclear medicine, 2019, Volume: 44, Issue:1 Topics: Adult; Brain; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Standards	2019
18F-FDG PET/CT: an unexpected case of Huntington's disease. BMC neurology, 2019, May-01, Volume: 19, Issue:1 Topics: Brain; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Positron Emission Tomography Computed Tomography	2019
Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI. Nuklearmedizin. Nuclear medicine, 2019, Volume: 58, Issue:5 Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Time Factors	2019
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease. Journal of neurology, 2014, Volume: 261, Issue:7 Topics: Adult; Cognition Disorders; Cohort Studies; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Psychomotor Disorders; Statistics, Nonparametric	2014
C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome. Journal of neurology, 2014, Volume: 261, Issue:10 Topics: Adult; Aged; C9orf72 Protein; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genetic Testing; Humans; Huntington Disease; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Proteins; Trinucleotide Repeat Expansion; Young Adult	2014
Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model. PloS one, 2014, Volume: 9, Issue:7 Topics: Animals; Blotting, Western; Cell Differentiation; Cells, Cultured; Corpus Striatum; Disease Models, Animal; DNA-Binding Proteins; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Huntington Disease; Immunohistochemistry; Induced Pluripotent Stem Cells; Male; Maze Learning; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Quinolinic Acid; Rats, Sprague-Dawley; Recovery of Function; Stem Cell Transplantation; Transplantation, Heterologous; X-Ray Microtomography	2014
FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study. Journal of Huntington's disease, 2015, Volume: 4, Issue:1 Topics: Animals; Animals, Genetically Modified; Brain; Case-Control Studies; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Huntington Disease; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats	2015
How reliable is European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:12 Topics: Brain Diseases, Metabolic; Corpus Striatum; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2016
Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation. Parkinsonism & related disorders, 2010, Volume: 16, Issue:1 Topics: Adult; Ataxia; Cognition Disorders; Electroencephalography; Family Health; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; TATA-Box Binding Protein; Temporal Lobe; Trinucleotide Repeat Expansion	2010
Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2011, Volume: 31, Issue:1 Topics: Adult; Aged; Blood Platelets; Brain; Brain Chemistry; Electron Transport Complex I; Electron Transport Complex III; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Image Processing, Computer-Assisted; Kinetics; Male; Middle Aged; Mitochondria; Oxidation-Reduction; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals	2011
Prediction of a new surface binding pocket and evaluation of inhibitors against huntingtin interacting protein 14: an insight using docking studies. Journal of molecular modeling, 2011, Volume: 17, Issue:12 Topics: Acyltransferases; Adaptor Proteins, Signal Transducing; Binding Sites; Enzyme Inhibitors; Fluorodeoxyglucose F18; Humans; Huntingtin Protein; Huntington Disease; Hydrogen Bonding; Metoprolol; Minocycline; Models, Molecular; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Protein Binding; Protein Structure, Tertiary; Tetracycline; Thermodynamics	2011
Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:5 Topics: Aged; Caudate Nucleus; Fluorodeoxyglucose F18; Glucose; Humans; Huntingtin Protein; Huntington Disease; Male; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Trinucleotide Repeats	2011
The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease. Neuropsychologia, 2011, Volume: 49, Issue:9 Topics: Adult; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Frontal Lobe; Human Activities; Humans; Huntington Disease; Mental Processes; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Reference Values; Serial Learning	2011
Genotype specific age related changes in a transgenic rat model of Huntington's disease. NeuroImage, 2011, Oct-15, Volume: 58, Issue:4 Topics: Aging; Animals; Autoradiography; Benzamides; Biomarkers; Brain; Cerebral Ventricles; Corpus Striatum; Diffusion Tensor Imaging; Fluorodeoxyglucose F18; Genotype; Huntington Disease; Image Processing, Computer-Assisted; Male; Phenotype; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Rats; Rats, Transgenic	2011
18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:6 Topics: Adult; Age of Onset; Biological Transport; Caudate Nucleus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Huntington Disease; Male; Middle Aged; Positron-Emission Tomography; Repetitive Sequences, Nucleic Acid; Young Adult	2012
Apparent relative hypermetabolism of selective brain areas in Huntington disease and importance of reference region for analysis. Clinical nuclear medicine, 2012, Volume: 37, Issue:7 Topics: Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Positron-Emission Tomography; Reference Standards	2012
A case of unilateral neglect in Huntington's disease. Neurocase, 2003, Volume: 9, Issue:3 Topics: Attention; Auditory Perception; Brain; Caudate Nucleus; Cognition Disorders; Electroencephalography; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Huntington Disease; Magnetic Resonance Imaging; Middle Aged; Perceptual Disorders; Radiopharmaceuticals; Tomography, Emission-Computed; Touch; Visual Perception	2003
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease. Journal of the neurological sciences, 2005, Apr-15, Volume: 231, Issue:1-2 Topics: Age Factors; Animals; Binding, Competitive; Body Weight; Brain; Brain Chemistry; Brain Mapping; Cerebral Cortex; Cystamine; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Fluorodeoxyglucose F18; Glucose; Huntington Disease; Image Processing, Computer-Assisted; Inclusion Bodies; Male; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Peptides; Positron-Emission Tomography; Raclopride; Transglutaminases; Tritium	2005
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology, 2005, Sep-27, Volume: 65, Issue:6 Topics: Adult; Binding, Competitive; Biomarkers; Corpus Striatum; Disease Progression; DNA Mutational Analysis; Dopamine; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Predictive Value of Tests; Raclopride; Receptors, Dopamine D2; Trinucleotide Repeat Expansion	2005
Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 11 Topics: Adult; Analysis of Variance; Case-Control Studies; Corpus Striatum; Disease Progression; Fluorodeoxyglucose F18; Gyrus Cinguli; Heterozygote; Humans; Huntington Disease; Longitudinal Studies; Male; Middle Aged; Motor Cortex; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Protein Binding; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Thalamus	2007
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Annals of neurology, 1982, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Atrophy; Blood Glucose; Brain; Caudate Nucleus; Cerebral Cortex; Cerebral Ventricles; Child; Corpus Striatum; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Putamen; Thalamus; Tomography, Emission-Computed; Tomography, X-Ray Computed	1982
Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Annals of neurology, 1984, Volume: 15 Suppl Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Tomography, X-Ray Computed	1984
Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more? Journal of neurology, 1995, Volume: 242, Issue:2 Topics: Adult; Alzheimer Disease; Basal Ganglia Diseases; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Tomography, Emission-Computed	1995
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. Journal of neurology, 1993, Volume: 241, Issue:1 Topics: Adolescent; Adult; Corpus Striatum; Deoxyglucose; Disease Susceptibility; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Glucose; Heterozygote; Humans; Huntington Disease; Male; Middle Aged; Neurologic Examination; Risk; Tomography, Emission-Computed	1993
Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:1 Topics: Adult; Blood Glucose; Cerebellum; Corpus Striatum; Deoxyglucose; Evoked Potentials, Somatosensory; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Neurocognitive Disorders; Risk Factors; Somatosensory Cortex; Tomography, Emission-Computed	1993
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain : a journal of neurology, 1996, Volume: 119 ( Pt 6) Topics: Adult; Carbon Radioisotopes; Caudate Nucleus; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Heterozygote; Humans; Huntington Disease; Male; Middle Aged; Mutation; Putamen; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed	1996
[Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:2 Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Huntington Disease; Image Processing, Computer-Assisted; Male; Middle Aged; Models, Biological; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed	2000
Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease. Experimental neurology, 2000, Volume: 166, Issue:2 Topics: Animals; Autoradiography; Benzazepines; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Energy Metabolism; Female; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Huntington Disease; In Situ Hybridization; Nerve Degeneration; Neurotoxins; Quinolinic Acid; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Substantia Nigra; Tomography, Emission-Computed; Tritium	2000
A primate model of Huntington's disease: functional neural transplantation and CT-guided stereotactic procedures. Cell transplantation, 1992, Volume: 1, Issue:4 Topics: Animals; Apomorphine; Brain Tissue Transplantation; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Deoxyglucose; Female; Fetal Tissue Transplantation; Fluorodeoxyglucose F18; Glucose; Graft Survival; Huntington Disease; Ibotenic Acid; Male; Motor Activity; Neurotoxins; Papio; Putamen; Quinolinic Acid; Rats; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed; Transplantation, Heterologous	1992
Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology, 1992, Volume: 42, Issue:9 Topics: Affect; Analysis of Variance; Deoxyglucose; Depression; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Huntington Disease; Limbic System; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed	1992
A method for comparing different procedures of estimating regional glucose metabolism using fluorine-18-fluorodeoxyglucose. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:1 Topics: Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Models, Statistical	1992
Cortical glucose metabolism in Huntington's disease. Neurology, 1992, Volume: 42, Issue:1 Topics: Adult; Aged; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Male; Middle Aged; Tissue Distribution; Tomography, Emission-Computed	1992
The FDG/PET methodology for early detection of disease onset: a statistical model. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1991, Volume: 11, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Caudate Nucleus; Deoxyglucose; Discriminant Analysis; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Huntington Disease; Kinetics; Middle Aged; Models, Statistical; Probability; Regression Analysis; Thalamus; Tomography, Emission-Computed	1991
Positron emission tomography as an imaging tool in psychiatric disorders. Psychiatry research, 1989, Volume: 29, Issue:3 Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Huntington Disease; Tomography, Emission-Computed	1989
Positron emission tomography in the early diagnosis of Huntington's disease. Neurology, 1986, Volume: 36, Issue:7 Topics: Adolescent; Adult; Aged; Caudate Nucleus; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Male; Middle Aged; Thalamus; Tomography, Emission-Computed; Tomography, X-Ray Computed	1986
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. The New England journal of medicine, 1987, Feb-12, Volume: 316, Issue:7 Topics: Adult; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Risk; Tomography, Emission-Computed	1987
Normal caudate glucose metabolism in persons at risk for Huntington's disease. Archives of neurology, 1987, Volume: 44, Issue:3 Topics: Adult; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Risk; Tomography, Emission-Computed	1987
Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET). Brain & development, 1988, Volume: 10, Issue:1 Topics: Adolescent; Brain; Child; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Male; Tomography, Emission-Computed	1988
Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Annals of neurology, 1988, Volume: 23, Issue:6 Topics: Adult; Brain; Cognition; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Organ Specificity; Reference Values; Tomography, Emission-Computed	1988
Cerebral metabolism of glucose in benign hereditary chorea. Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:1 Topics: Adult; Brain; Caudate Nucleus; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Pedigree; Thalamus; Tomography, Emission-Computed	1986
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Research publications - Association for Research in Nervous and Mental Disease, 1985, Volume: 63 Topics: Adolescent; Adult; Alzheimer Disease; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed; Tomography, X-Ray Computed	1985